Cargando…
A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions
Interleukin-7 (IL-7) is an essential cytokine for T-cell homeostatic proliferation and maintenance. Clinical studies have shown the potential benefits of IL-7 therapy in various diseases associated with lymphopenia. However, the kinetics of the T-cell response to a single administration of IL-7 in h...
Autores principales: | Kim, Sojeong, Lee, Sang Won, Koh, June-Young, Choi, Donghoon, Heo, Minkyu, Chung, Jae-Yong, Lee, Byung Ha, Yang, Se Hwan, Sung, Young Chul, Lee, Howard, Shin, Eui-Cheol, Park, Su-Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772483/ https://www.ncbi.nlm.nih.gov/pubmed/36206199 http://dx.doi.org/10.1182/bloodadvances.2021006591 |
Ejemplares similares
-
hIL‐7‐hyFc, A Long‐Acting IL‐7, Increased Absolute Lymphocyte Count in Healthy Subjects
por: Lee, Sang Won, et al.
Publicado: (2020) -
Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma
por: Ahn, Stephen, et al.
Publicado: (2022) -
Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc
por: O’Neal, Julie, et al.
Publicado: (2023) -
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
por: Kim, Miriam Y., et al.
Publicado: (2022) -
Detection and characterization of the S. typhimurium HilA protein
por: Rodriguez, Christine R, et al.
Publicado: (2002)